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CASE REPORT
Common Creatine Kinase gene mutation results in
falsely reassuring CK levels in muscle disorders
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From the 1Division of Cardiovascular & Diabetes Medicine, University of Dundee, Ninewells Hospital &
Medical School, Dundee DD1 9SY, UK
Address correspondence to Dr J. George, School of Medicine, University of Dundee, Dundee DD1 9SY, Scotland, UK. email: j.george@dundee.ac.uk
Learning point for clinicians
The mean allele frequency of this SNP is 0.02 (2.5 mil-
lion people in the UK are carriers). Therefore, greater
awareness of this CKM SNP is needed as there may be
instances where the diagnosis of rhabdomyolysis, statin-
induced myopathy, poly-/dermatomyositis and other
muscle conditions that result in raised CK’s, is missed in
these patients.
Introduction
Creatine Kinase (CK) is the enzyme responsible for catalysing
the exchange of phosphates in the creatine/phosphocreatine
shuttle.1 Skeletal muscle CK is made up of 90% muscle CK (CK-
MM) and 10% heart CK (CK-MB).2,3 In muscle damage (e.g.
rhabdomyolysis), extreme exercise and statin-induced myositis,
serum CK can be raised in excess of 10 times the upper limit of
normal.4 However, the recent discovery of a single nucleotide
polymorphism(SNP), rs11559024 in the CKM gene5 results in an
inability to produce skeletal muscle type CK and therefore low
levels of CK in clinical scenarios that may result in crucial diag-
nosis such as rhabdomyolysis and statin-induced myositis
being missed.
Case report
A female patient was found to be homozygous for rs11559024
with consistently low CK values. The patient had a past history
of Type 2 Diabetes Mellitus, Chronic Kidney Disease and
Peripheral Vascular Disease.
Following an admission with extensive necrotising fasciitis,
she underwent a debridement procedure for extensive necrotis-
ing fasciitis. Post-operative blood samples indicated her CK
reached a maximum of 22 IU/l [nr 35-175 IU/l] the day after her
surgery. Whilst recovering this patient’s CK returned to 8 IU/l
within 48 h after the operation.
Further admissions in subsequent years for a hemicolec-
tomy (for bowel cancer) also revealed significant blunting in her
expected CK levels post-operatively. Her pre-operative CK of
34 IU/l remained relatively unchanged post-operatively (28 IU/l).
Discussion
As a carrier of two copies of the rare allele at the SNP rs11559024
of her CKM gene, this patient was unable to produce measurable
functioning skeletal muscle type CK resulting in consistently
low serum CK even following necrotising fasciitis and open sur-
gery. In her past history, the patient was also deemed ‘intoler-
ant’ to statins and was switched multiple times between
different statins. Her CK levels were falsely reassuring when
checked by clinicians looking for evidence of a statin-induced
myositis.
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